Medical Research Agency News

We'll know the results of the amantadine study in a few weeks

The Agency for Medical Research, in response to a request from Minister of Health Adam Niedzielski, funded a study on the use of amantadine in preventing progression and treating symptoms of COVID-19. The study aims to confirm whether the incoming reports of the efficacy of a substance previously used to treat Parkinson's also prevents the development of COVID-19.

Non-commercial clinical trial of CAR-T therapy with Medical Research Agency funding

Medical Research Agency has signed a contract for the implementation of the project called "Polish Chimeric Antigen Receptor T-cell Network", thanks to which patients in Poland will have access to the most modern treatment methods.

Medical Research Agency year-end summary - support for academic research

Schedule of Medical Research Agency calls for 2021

Medical Research Agency summarised year of work and outlines plans for 2021

Medical Research Agency as part of a conference entitled " Poles' health priorities for 2021. The role of the Agency in creating changes in clinical practice" summarized the activities to date and presented plans for next year. Key areas supported by ABM in 2021 will include. rare diseases, mental health and therapies for lifestyle diseases.

PLN 100 million for civilization diseases - III edition of the competition for non-commercial clinical research

Civilization diseases are responsible for more than 80 percent of the world's population. premature deaths, with cardiovascular and oncological diseases taking the heaviest toll. Innovative therapies and prevention programs can provide improvement in this area. The work of specialists in this field is supported by the Medical Research Agency which offers co-financing for the most promising projects selected in its competitions.

Medical Research Agency will donate PLN 100 million for research on rare diseases

There are several thousand rare diseases and up to 8% may be affected. population. 80 percent. of which are genetic. Next year, the Medical Research Agency plans to allocate PLN 100 million to expand access to innovative therapies for these diseases, among others.

Results of the call for development of Polish adoptive therapy (CAR/CAR-T)

The Medical Research Agency has announced the results of the competition to develop a Polish adoptive therapy (CAR/CAR-T). In the coming days a funding agreement will be signed, which will launch an unprecedented in Polish history program for the development of ultra-modern oncological therapy.

Cooperation between the Medical Research Agency and the National Science Center

President of the Medical Research Agency Radosław Sierpiński, MD, PhD and Director of the National Science Centre Professor Zbigniew Błocki signed an agreement on cooperation, including in particular mutual support in using the results of research and implementation of innovations in the health care system.

Medical Research Agency laureate of the Polish Intelligent Development Award 2020

Medical Research Agency has been awarded the Polish Intelligent Development Award 2020 in the category: Merit for the health of the society for actions taken to build an innovative health care system and to develop research in the field of medical and health sciences. The award ceremony will take place as part of this year's 5th edition. Intelligent Development Forum in Uniejów.